Moneycontrol PRO

business

Aashish Tater bullish on pharma sectors for long-term

In an interview to CNBC-TV 18 Aashish Tater, Head of Research, Fortunewizard.com is bullish on Pharma sector. He discusses Glenmark and Cipla which are a buy for atleast a period of 12-18 months.

first published: Nov 15, 2012 12:25 pm

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347